139 related articles for article (PubMed ID: 8428329)
1. Ketoconazole and liarozole in the treatment of advanced prostatic cancer.
Mahler C; Verhelst J; Denis L
Cancer; 1993 Feb; 71(3 Suppl):1068-73. PubMed ID: 8428329
[TBL] [Abstract][Full Text] [Related]
2. P450-dependent enzymes as targets for prostate cancer therapy.
De Coster R; Wouters W; Bruynseels J
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):133-43. PubMed ID: 8603034
[TBL] [Abstract][Full Text] [Related]
3. Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer.
Harris KA; Weinberg V; Bok RA; Kakefuda M; Small EJ
J Urol; 2002 Aug; 168(2):542-5. PubMed ID: 12131305
[TBL] [Abstract][Full Text] [Related]
4. Liarozole--a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate. Liarozole Study Group.
Debruyne FJ; Murray R; Fradet Y; Johansson JE; Tyrrell C; Boccardo F; Denis L; Marberger JM; Brune D; Rassweiler J; Vangeneugden T; Bruynseels J; Janssens M; De Porre P
Urology; 1998 Jul; 52(1):72-81. PubMed ID: 9671874
[TBL] [Abstract][Full Text] [Related]
5. New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens.
Labrie F; Dupont A; Belanger A; Lacoursiere Y; Raynaud JP; Husson JM; Gareau J; Fazekas AT; Sandow J; Monfette G
Prostate; 1983; 4(6):579-94. PubMed ID: 6415630
[TBL] [Abstract][Full Text] [Related]
6. Ketoconazole therapy in advanced prostatic cancer.
Trachtenberg J
J Urol; 1984 Jul; 132(1):61-3. PubMed ID: 6328052
[TBL] [Abstract][Full Text] [Related]
7. Early clinical experience with liarozole (Liazal) in patients with progressive prostate cancer.
Denis L; Debruyne F; De Porre P; Bruynseels J
Eur J Cancer; 1998 Mar; 34(4):469-75. PubMed ID: 9713295
[TBL] [Abstract][Full Text] [Related]
8. Objective responses to ketoconazole therapy in patients with relapsed progressive prostatic cancer.
Williams G; Kerle DJ; Ware H; Doble A; Dunlop H; Smith C; Allen J; Yeo T; Bloom SR
Br J Urol; 1986 Feb; 58(1):45-51. PubMed ID: 3947856
[TBL] [Abstract][Full Text] [Related]
9. Long-term experience with high dose ketoconazole therapy in patients with stage D2 prostatic carcinoma.
Pont A
J Urol; 1987 May; 137(5):902-4. PubMed ID: 2437334
[TBL] [Abstract][Full Text] [Related]
10. Effects of high-dose ketoconazole in patients with androgen-independent prostatic cancer.
Eichenberger T; Trachtenberg J
Am J Clin Oncol; 1988; 11 Suppl 2():S104-7. PubMed ID: 3242385
[TBL] [Abstract][Full Text] [Related]
11. Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys.
Yamaoka M; Hara T; Hitaka T; Kaku T; Takeuchi T; Takahashi J; Asahi S; Miki H; Tasaka A; Kusaka M
J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):115-28. PubMed ID: 22249003
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of intermediate-dose ketoconazole in hormone refractory prostate cancer.
Wilkinson S; Chodak G
Eur Urol; 2004 May; 45(5):581-4; discussion 585. PubMed ID: 15082199
[TBL] [Abstract][Full Text] [Related]
13. High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.
Trump DL; Havlin KH; Messing EM; Cummings KB; Lange PH; Jordan VC
J Clin Oncol; 1989 Aug; 7(8):1093-8. PubMed ID: 2474059
[TBL] [Abstract][Full Text] [Related]
14. Liarozole.
Bryson HM; Wagstaff AJ
Drugs Aging; 1996 Dec; 9(6):478-84; discussion 485. PubMed ID: 8972247
[TBL] [Abstract][Full Text] [Related]
15. [High dosage ketoconazole therapy in the treatment of advanced prostatic cancer].
Flamm J; Sagaster P; Teich G; Köhn H; Miksche M
Urologe A; 1988 Mar; 27(2):111-6. PubMed ID: 3376369
[TBL] [Abstract][Full Text] [Related]
16. Effects of high-dose ketoconazole on patients who have androgen-independent prostatic cancer.
Eichenberger T; Trachtenberg J
Can J Surg; 1989 Sep; 32(5):349-52. PubMed ID: 2475237
[TBL] [Abstract][Full Text] [Related]
17. High-dose ketoconazole treatment in advanced prostatic cancer.
Scultéty S; Oszlánczy J; Faredin I; Tóth I
Int Urol Nephrol; 1988; 20(4):383-93. PubMed ID: 3170109
[TBL] [Abstract][Full Text] [Related]
18. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
Labrie F; Dupont A; Belanger A; Lefebvre FA; Raynaud JP
J Pharmacol; 1983; 14 Suppl 3():117-35. PubMed ID: 6423907
[TBL] [Abstract][Full Text] [Related]
19. Ketoconazole: a novel and rapid treatment for advanced prostatic cancer.
Trachtenberg J; Halpern N; Pont A
J Urol; 1983 Jul; 130(1):152-3. PubMed ID: 6306286
[TBL] [Abstract][Full Text] [Related]
20. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
Lamberts SW; Uitterlinden P; de Jong FH
Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
